OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Release Date
2022
(2)
2016
(2)
2015
(2)
2013
(2)
2025
(1)
2024
(1)
2023
(1)
2021
(1)
2018
(1)
2014
(1)
2012
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial.
Not available
S-EPMC12382509
|
biostudies-literature
Cite
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Not available
S-EPMC6246813
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276
|
biostudies-literature
Cite
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3536921
|
biostudies-literature
Cite
Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4808340
|
biostudies-literature
Cite
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC3737287
|
biostudies-literature
Cite
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4549177
|
biostudies-literature
Cite
Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4766028
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets